These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


364 related items for PubMed ID: 24166792

  • 1. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
    de Rotte MC, de Jong PH, Pluijm SM, Calasan MB, Barendregt PJ, van Zeben D, van der Lubbe PA, de Sonnaville PB, Lindemans J, Hazes JM, de Jonge R.
    Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML.
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [Abstract] [Full Text] [Related]

  • 3. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P, Naik S, Mishra KP, Aggarwal A, Misra R.
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.
    de Rotte MC, den Boer E, de Jong PH, Pluijm SM, Ćalasan MB, Weel AE, Huisman AM, Gerards AH, van Schaeybroeck B, Wulffraat NM, Lindemans J, Hazes JM, de Jonge R.
    Ann Rheum Dis; 2015 Feb; 74(2):408-14. PubMed ID: 24297383
    [Abstract] [Full Text] [Related]

  • 7. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 8. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E, de Rotte MC, Pluijm SM, Heil SG, Hazes JM, de Jonge R.
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [Abstract] [Full Text] [Related]

  • 9. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N, Ellingsen T, Stengaard-Pedersen K, Poulsen JH.
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [Abstract] [Full Text] [Related]

  • 10. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM.
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [Abstract] [Full Text] [Related]

  • 11. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 12. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, Kerstens PJ, van Zeben D, Breedveld FC, Dijkmans BA, Huizinga TW, Guchelaar HJ.
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [Abstract] [Full Text] [Related]

  • 16. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.
    Weisman MH, Furst DE, Park GS, Kremer JM, Smith KM, Wallace DJ, Caldwell JR, Dervieux T.
    Arthritis Rheum; 2006 Feb; 54(2):607-12. PubMed ID: 16447238
    [Abstract] [Full Text] [Related]

  • 17. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J.
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: results of a phase II multicenter randomized study.
    Keystone EC, Shirinsky VS, Simon LS, Pedder S, Hewitt LA, CH-1504 Study Group.
    J Rheumatol; 2011 Sep; 38(9):1875-83. PubMed ID: 21724705
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
    Stamp LK, Chapman PT, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Kennedy MA, Roberts RL.
    Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.